N-naphthalen-1-ylmethyl-2'-[3,5-dimethoxybenzamido]-2'-deoxy-adenosine

Star0

DB03331ExperimentalSmall molecule

N-naphthalen-1-ylmethyl-2'-[3,5-dimethoxybenzamido]-2'-deoxy-adenosine: Overview.

Formula / weight: C₃₀H₃₀N₆O₆ · 570.5958 g/mol (avg)
Also known as: 2'-Deoxy-2'-[(3,5-dimethoxybenzoyl)amino]-N-(1-naphthylmethyl)adenosine

Resolves to

Compound

ChEMBLCHEMBL303934PubChem446186

Structure

InChIKeyOARVXDFNTLYMCJ-JVUUKAHWSA-NSMILES[H]N(CC1=CC=CC2=CC=CC=C12)C1=C2N=CN([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3N([H])C(=O)C3=CC(OC)=CC(OC)=C3)C2=NC=N1

Targets

O14556GAPDHS

What you can answer from here — as of August 31, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with N-naphthalen-1-ylmethyl-2'-[3,5-dimethoxybenzamido]-2'-deoxy-adenosine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account